- Home
- PMCB vs LIQT Comparison
PMCB vs LIQT Comparison
Compare PMCB & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMCB | LIQT |
|---|---|---|
| Founded | 1996 | 2004 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 13.7M |
| IPO Year | 2001 | 2011 |
Fundamental Metrics
Financial Performance| Metric | PMCB | LIQT |
|---|---|---|
| Price | $0.70 | $1.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.30 |
| AVG Volume (30 Days) | ★ 152.8K | 84.1K |
| Earning Date | 03-17-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 277.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $42.12 |
| Revenue Next Year | N/A | $63.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $1.22 |
| 52 Week High | $1.51 | $3.35 |
Technical Indicators
Market Signals| Indicator | PMCB | LIQT |
|---|---|---|
| Relative Strength Index (RSI) | 47.14 | 60.66 |
| Support Level | $0.65 | $1.80 |
| Resistance Level | $0.77 | $2.00 |
| Average True Range (ATR) | 0.07 | 0.25 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 34.90 | 79.27 |
Price Performance
Historical ComparisonAbout PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in businesses that are liquid filtration market and the silicon carbide ceramic membrane & diesel particulate filter (DPF) market. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and others. Its operating segment includes Water, Ceramics, and Plastics.